Tian Xu
Tian Xu received his BS degree in Genetics in 1982 from Fudan University, Shanghai and his PhD from Yale University in 1990. This was followed by a post-doc position (1990-1993) in neural development at the University of California at Berkeley. Since that time he has held positions at Yale University and is currently Professor of Genetics, Molecular Oncology and Development and Vice Chair of Genetics. He is an Investigator of the Howard Hughes Medical Institute and since 1996 has also been Adjunct Professor at Fudan University, becoming Director of the Fudan University Institute of Developmental Biology and Molecular Medicine in 2002.
Among his many awards have included the Tuberous Sclerosis Alliance Rothberg Courage Award, the Shanghai Science and Technology Award and the Magnolia Silver Award, Shanghai.
He is a member of the Genetics Society of America and the American Association of Cancer Reseach. He was Vice President of the Ray Wu Society (2000-2002), Treasurer of the Society of Chinese Bioscientists in America (2000-2004) and President of the Chinese Biological Investigators Society (2002-2005).
Professor Xu's research focuses on cancer biology and seeks to understand developmental mechanisms using model organisms. His group are seeking to identify genes involved in tumour growth and metastasis and are exploring the developmental and biochemical functions of these genes.
A very promising outcome of this research has been the development of a highly efficient single transposon mutagenesis strategy and the near-production of the first set of genome-wide insertional mutants in mice. This will provide an opportunity for deciphering mammalian biology and disease.
